Literature DB >> 8035940

The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia.

K Marder1, G Maestre, L Cote, H Mejia, B Alfaro, A Halim, M Tang, B Tycko, R Mayeux.   

Abstract

The epsilon 4 isoform of apolipoprotein E (Apo-E) may confer genetic susceptibility for familial and sporadic Alzheimer's disease (AD). Because dementia in AD and Parkinson's disease (PD) share many biologic and clinical features, we determined the Apo-E genotypes for 79 patients with PD, 22 of whom were demented, and for 44 age-matched healthy elderly controls from the same community. We hypothesized that if the dementia was similar to AD, there would be a higher allele frequency of apolipoprotein epsilon 4 (Apo epsilon 4) in demented PD patients compared with nondemented PD patients and controls. The epsilon 4 allele frequency for PD without dementia was 0.132, for PD with dementia, 0.068, and for controls, 0.102. There was no association between Apo epsilon 4 and dementia in the PD patients. We conclude that the biologic basis for dementia in PD may differ from that of AD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035940     DOI: 10.1212/wnl.44.7.1330

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  What can biomarkers tell us about cognition in Parkinson's disease?

Authors:  Brit Mollenhauer; Lynn Rochester; Alice Chen-Plotkin; David Brooks
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

2.  Genetic influences on cognitive decline in Parkinson's disease.

Authors:  James F Morley; Sharon X Xie; Howard I Hurtig; Matthew B Stern; Amy Colcher; Stacy Horn; Nabila Dahodwala; John E Duda; Daniel Weintraub; Alice S Chen-Plotkin; Vivianna Van Deerlin; Dana Falcone; Andrew Siderowf
Journal:  Mov Disord       Date:  2012-02-16       Impact factor: 10.338

3.  APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.

Authors:  Thomas F Tropea; Sharon X Xie; Jacqueline Rick; Lana M Chahine; Nabila Dahodwala; Jimit Doshi; Christos Davatzikos; Leslie M Shaw; Vivianna Van Deerlin; John Q Trojanowski; Daniel Weintraub; Alice S Chen-Plotkin
Journal:  Mov Disord       Date:  2017-11-23       Impact factor: 10.338

4.  Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.

Authors:  A S Whitehead; S Bertrandy; F Finnan; A Butler; G D Smith; Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 5.  Nuclear and mitochondrial genetics in Parkinson's disease.

Authors:  A H Schapira
Journal:  J Med Genet       Date:  1995-06       Impact factor: 6.318

6.  Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia.

Authors:  M G Martinoli; J Q Trojanowski; M L Schmidt; S E Arnold; T M Fujiwara; V M Lee; H Hurtig; J P Julien; C Clark
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Parkinson's, Alzheimer's, and motor neurone disease.

Authors:  Y Ben-Shlomo; A S Whitehead; G D Smith
Journal:  BMJ       Date:  1996-03-23

Review 8.  Relationship between Apolipoprotein Superfamily and Parkinson's Disease.

Authors:  Lin Li; Ming-Su Liu; Guang-Qin Li; Jie Tang; Yan Liao; Yang Zheng; Tong-Li Guo; Xin Kang; Mao-Ting Yuan
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

Review 9.  A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders.

Authors:  Sagrario Manzano; Luis Agüera; Miquel Aguilar; Javier Olazarán
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.